CD14 and non-small cell lung carcinoma: Huang A et al. [39] have shown that both frequency and absolute number of CD14(+)HLA-DR(-/low) cells were significantly increased in the peripheral blood of NSCLC patients compared with that of the healthy subjects and indicated an association with metastasis, poor response to chemotherapy and progression-free survival.